Hologic CFO Awarded 17,095 Performance Stock Units
HOLOGIC INC
Subscribe to track HOLX
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Hologic CFO Awarded 17,095 Performance Stock Units
Company: HOLOGIC INC (HOLX) Form: 4 | Filed: 2025-11-06 Significance: Low
Insider: Oberton Karleen Marie Title: Chief Financial Officer | Relationship: Officer
Transaction: • Type: Grant • Shares: 17,095 • Price: $0.00 • Value: $0 • Owned After: 119,203
Key Insight: Routine grant of performance stock units to the CFO as part of an established compensation plan. The transaction has no cash value and does not reflect an open-market decision.
Market Context: The grant represents a negligible 0.008% of total shares outstanding for the $16.49B company, indicating minimal dilution or market impact.
Comprehensive Analysis
SEC Filing Analysis: HOLOGIC INC (HOLX)
Executive Summary
- Trading Significance: Low
- Key Takeaway: Hologic's CFO, Karleen Marie Oberton, was awarded 17,095 performance stock units as part of her compensation package.
- Market Impact: Neutral. This is a non-cash, routine grant with negligible impact on the company's market capitalization or share structure.
Company Information
| Field | Value |
|---|---|
| Company | HOLOGIC INC |
| Ticker Symbol | HOLX |
| CIK | 0000859737 |
| Industry | X-RAY APPARATUS & TUBES & RELATED IRRADIATION APPARATUS |
Insider Information
| Field | Value |
|---|---|
| Name | Oberton Karleen Marie |
| CIK | 0001314036 |
| Title/Position | Chief Financial Officer |
| Relationship | Officer |
Transaction Details
| Field | Value |
|---|---|
| Form Type | 4 |
| Transaction Date | 2025-11-04 |
| Transaction Code | A (Award) |
| Security Type | Common Stock (via Performance Stock Units) |
| Shares Involved | 17,095 |
| Price Per Share | $0.00 |
| Total Value | $0 |
| Shares Owned After | 119,203 |
| Ownership Type | Direct |
Financial Impact Assessment
Transaction Materiality
| Metric | Value |
|---|---|
| Transaction Value | $0 |
| % of Market Cap | 0.00% |
| Shares Transacted | 17,095 |
| % of Shares Outstanding | 0.008% |
| Post-Transaction Ownership | 119,203 shares (0.054% of outstanding) |
| Materiality Assessment | Low |
Impact Evaluation
- Market Cap Context: The transaction has no monetary value and is immaterial against Hologic's $16.49 billion market capitalization.
- Ownership Concentration: The CFO's post-transaction ownership remains very low at 0.054% of total shares outstanding.
- Dilution Impact: The grant results in a minor potential dilution of 0.008%, which is a standard and expected part of executive compensation for a company of this size.
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: This is a scheduled compensation-related grant, not an open-market transaction. It does not signal any new information about the insider's view of the company's future prospects.
Volume & Sentiment
- Expected Volume Impact: None. The transaction is not a market trade and will not affect trading volume.
- Sentiment Indicator: Neutral. The market typically views such routine grants as standard business practice.
Additional Context
Transaction Notes
- The filing indicates these are Performance Stock Units (PSUs) where performance criteria have been met. The shares remain subject to service-based vesting requirements, as noted in the filing's footnotes.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.
